Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million

Stock Information for Prenetics Global Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Prenetics Global Limited

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure
Prenetics Announces Upcoming Conference Participation

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.